| 000 | 01542 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512054051.0 | ||
| 264 | 0 | _c19870529 | |
| 008 | 198705s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/19.3.367 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRolston, K V | |
| 245 | 0 | 0 |
_aCeftizoxime plus ticarcillin: double beta-lactam therapy for infections in cancer patients. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cMar 1987 |
||
| 300 |
_a367-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBacterial Infections _xcomplications |
| 650 | 0 | 4 |
_aCefotaxime _xanalogs & derivatives |
| 650 | 0 | 4 | _aCeftizoxime |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFever |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aPenicillins _xtherapeutic use |
| 650 | 0 | 4 |
_aPneumonia _xcomplications |
| 650 | 0 | 4 |
_aSepsis _xcomplications |
| 650 | 0 | 4 |
_aTicarcillin _xtherapeutic use |
| 700 | 1 | _aJones, P G | |
| 700 | 1 | _aFainstein, V | |
| 700 | 1 | _aElting, L | |
| 700 | 1 | _aBodey, G P | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 19 _gno. 3 _gp. 367-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/19.3.367 _zAvailable from publisher's website |
| 999 |
_c3477481 _d3477481 |
||